A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Pfizer
Pfizer
Isofol Medical AB
TG Therapeutics, Inc.
Amgen
Leaf Vertical Inc.
Hoffmann-La Roche
Pfizer
Mast Therapeutics, Inc.
Mast Therapeutics, Inc.